[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Connect Biopharma Holdings Ltd ADR (CNTB)

Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Connect Biopharma Holdings Ltd ADR 3580 CARMEL MOUNTAIN ROAD SUITE 200 SAN DIEGO CA 92130 USA

www.connectbiopharm.com Employees: 64 P: 877-245-2787

Sector:

Medical

Description:

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from our T cell-driven research. The company's product candidate includes CBP-201. Connect Biopharma Holdings Limited is based in TAICANG, China.

Key Statistics

Overview:

Market Capitalization, $K 145,447
Enterprise Value, $K 107,097
Shares Outstanding, K 62,964
Float, K 48,734
% Float 77.40%
Short Interest, K 1,134
Short Float 1.80%
Days to Cover 4.82
Short Volume Ratio 0.40
% of Insider Shareholders 22.60%
% of Institutional Shareholders 58.72%

Financials:

Annual Sales, $ 60 K
Annual Net Income, $ -55,480 K
Last Quarter Sales, $ 170 K
Last Quarter Net Income, $ -19,400 K
EBIT, $ -66,240 K
EBITDA, $ -65,540 K

Growth:

1-Year Return 189.57%
3-Year Return 99.14%
5-Year Return -84.48%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 05/12/26
Next Earnings Date 08/12/26
Earnings Per Share ttm -1.15
EPS Growth vs. Prev Qtr -25.93%
EPS Growth vs. Prev Year -78.95%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CNTB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -122.29%
Return-on-Assets % -97.07%
Profit Margin % -92,466.67%
Debt/Equity 0.00
Price/Sales 2,154.55
Price/Cash Flow N/A
Price/Book 2.90
Book Value/Share 0.75
Interest Coverage -1.72
60-Month Beta -0.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.